药格局YaoGeJu

Public records · Updated regularly

China generic drug landscapes

Public records on generic drug applications, companies and approvals in China, with dated Chinese official sources.

Selection: the top 30 chemical-drug generic names in national 2026 generic filings, ranked by distinct first applicants, then filing count descending and normalized name ascending. Width and whitespace are normalized; dosage forms and combinations remain separate. Recalculated on Mondays; published pages remain available.

Selection week: 2026/11/02

01

Dapagliflozin Tablets(达格列净片)

Last 90 days: Marketing application approved: 4 applications · Accepted: 19 applications

At selection: 28 filing companies · 51 filings

Selection week: 2026/11/02
 02

Edaravone and Dexborneol Concentrated Solution for Injection(依达拉奉右莰醇注射用浓溶液)

Last 90 days: Accepted: 5 applications

At selection: 27 filing companies · 27 filings

Selection week: 2026/11/02
 03

Nafamostat Mesilate for Injection(注射用甲磺酸萘莫司他)

Last 90 days: Accepted: 3 applications

At selection: 24 filing companies · 41 filings

Selection week: 2026/11/02
 04

多替诺雷片

Last 90 days: Accepted: 22 applications · Approval-document delivery record: 1 application

At selection: 23 filing companies · 45 filings

Selection week: 2026/11/02
 05

Glucosamine Sulfate Capsules(硫酸氨基葡萄糖胶囊)

Last 90 days: Marketing application approved: 2 applications · Accepted: 14 applications

At selection: 23 filing companies · 23 filings

Selection week: 2026/11/02
 06

瑞维那新吸入溶液

Last 90 days: Accepted: 3 applications · Notification delivery: 1 application

At selection: 21 filing companies · 23 filings

Selection week: 2026/11/02
 07

Mirogabalin Besilate Tablets(苯磺酸美洛加巴林片)

Last 90 days: Accepted: 11 applications

At selection: 20 filing companies · 38 filings

Selection week: 2026/11/02
 08

Upadacitinib Sustained-release Tablets(乌帕替尼缓释片)

Last 90 days: Marketing application approved: 3 applications · Accepted: 7 applications

At selection: 18 filing companies · 18 filings

Selection week: 2026/11/02
 09

Landiolol Hydrochloride for Injection(注射用盐酸兰地洛尔)

Last 90 days: Accepted: 6 applications

At selection: 17 filing companies · 17 filings

Selection week: 2026/11/02
 10

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)(达格列净二甲双胍缓释片(I))

Last 90 days: Marketing application approved: 3 applications · Accepted: 8 applications

At selection: 16 filing companies · 20 filings

Selection week: 2026/11/02
 11

Mupirocin Ointment(莫匹罗星软膏)

Last 90 days: Marketing application approved: 4 applications · Accepted: 11 applications

At selection: 16 filing companies · 18 filings

Selection week: 2026/11/02
 12

氧

Last 90 days: Marketing application approved: 1 application · Accepted: 5 applications

At selection: 16 filing companies · 16 filings

Selection week: 2026/11/02
 13

Baricitinib Tablets(巴瑞替尼片)

Last 90 days: Marketing application approved: 2 applications · Accepted: 5 applications

At selection: 15 filing companies · 21 filings

Selection week: 2026/11/02
 14

Adapalene And Benzoyl Peroxide Gel(阿达帕林过氧苯甲酰凝胶)

Last 90 days: Accepted: 4 applications · No longer listed under review: 3 applications

At selection: 15 filing companies · 19 filings

Selection week: 2026/11/02
 15

氧(液态)

Last 90 days: Marketing application approved: 1 application · Accepted: 8 applications

At selection: 15 filing companies · 15 filings

Selection week: 2026/11/02
 16

Oseltamivir Phosphate Capsules(磷酸奥司他韦胶囊)

Last 90 days: Marketing application approved: 4 applications · Accepted: 15 applications

At selection: 14 filing companies · 25 filings

Selection week: 2026/11/02
 17

Sodium Hyaluronate Eye Drops(玻璃酸钠滴眼液)

Last 90 days: Marketing application approved: 3 applications · Accepted: 13 applications

At selection: 13 filing companies · 21 filings

Selection week: 2026/11/02
 18

注射用磷酸左奥硝唑酯二钠

Last 90 days: Accepted: 6 applications

At selection: 13 filing companies · 14 filings

Selection week: 2026/11/02
 19

Iguratimod Tablets(艾拉莫德片)

Last 90 days: Marketing application approved: 3 applications · Accepted: 2 applications

At selection: 13 filing companies · 13 filings

Selection week: 2026/11/02
 20

Ferrous Succinate Tablets(琥珀酸亚铁片)

Last 90 days: Marketing application approved: 1 application · Accepted: 4 applications

At selection: 12 filing companies · 12 filings

Selection week: 2026/11/02
 21

Sacubitril Valsartan Sodium Tablets(沙库巴曲缬沙坦钠片)

Last 90 days: Marketing application approved: 2 applications · Accepted: 9 applications

At selection: 11 filing companies · 23 filings

Selection week: 2026/11/02
 22

Finerenone Tablets(非奈利酮片)

Last 90 days: Accepted: 7 applications · No longer listed under review: 2 applications

At selection: 11 filing companies · 17 filings

Selection week: 2026/11/02
 23

Ambroxol Hydrochloride Oral Solution(盐酸氨溴索口服溶液)

Last 90 days: Accepted: 10 applications

At selection: 11 filing companies · 16 filings

Selection week: 2026/11/02
 24

Ilaprazole Enteric-coated Tablets(艾普拉唑肠溶片)

Last 90 days: Marketing application approved: 1 application · Accepted: 3 applications

At selection: 11 filing companies · 13 filings

Selection week: 2026/11/02
 25

Crisaborole Ointment(克立硼罗软膏)

Last 90 days: Accepted: 3 applications · No longer listed under review: 1 application

At selection: 11 filing companies · 12 filings

Selection week: 2026/11/02
 26

Ertugliflozin Tablets(艾托格列净片)

Last 90 days: Accepted: 6 applications

At selection: 11 filing companies · 11 filings

Selection week: 2026/11/02
 27

Iron Proteinsuccinylate Oral Solution(蛋白琥珀酸铁口服溶液)

Last 90 days: Accepted: 3 applications

At selection: 11 filing companies · 11 filings

Selection week: 2026/11/02
 28

Loxoprofen Sodium Patches(洛索洛芬钠贴剂)

Last 90 days: Accepted: 2 applications

At selection: 10 filing companies · 18 filings

Selection week: 2026/11/02
 29

Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution(氨溴特罗口服溶液)

Last 90 days: Marketing application approved: 3 applications · Accepted: 2 applications

At selection: 10 filing companies · 13 filings

Selection week: 2026/11/02
 30

聚乙烯醇滴眼液

Last 90 days: Marketing application approved: 1 application · Accepted: 2 applications

At selection: 10 filing companies · 12 filings

Selection week: 2026/11/02